| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b8603ee14f13e9c3d3f6d5858bf4f3bf |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y304-21021 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-4846
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-65 |
| filingDate |
2018-10-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b7704bb66ba28a8bf417b45d4cb3fae6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fe582453a0ab0c46da67b485991be18c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_decb8dd7bcf0148bd7fb632e66cc2030
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f7e1ab2721945b9ff914bea27d547414
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d78bb2c9796ffc6b002e89d51f0b93d0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ef3e0407d0c38d0576601e714ca9c8d |
| publicationDate |
2019-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2019030318-A |
| titleOfInvention |
Method for virus inactivation in compositions containing blood coagulation factor VII |
| abstract |
Disclosed is a method for virus inactivation in a composition comprising blood coagulation factor VII (factor VII, FacVII) or a derivative thereof. The present invention relates to a method for inactivating viruses in a composition containing blood coagulation factor VII, and more particularly, a surfactant in a composition containing blood coagulation factor VII or a derivative thereof. And a method for producing a virus inactivating composition containing blood coagulation factor VII or a derivative thereof in which the virus is inactivated. [Selection] Figure 2 |
| priorityDate |
2013-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |